NGM BIOPHARMACEUTICALS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at NGM BIOPHARMACEUTICALS is $111,072, based on 23 certified filings from FY 2020 to FY 2025. This is 7% lower than the national H-1B median salary of $120,000. Compensation at NGM BIOPHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $96,000 and senior positions reaching $174,468 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at NGM BIOPHARMACEUTICALS range from $80,155 at the 10th percentile to $174,468 at the 90th percentile, showing a $94,313 spread across experience levels and roles. The 25th percentile is $96,000 and the 75th percentile is $132,000.

Yes, NGM BIOPHARMACEUTICALS actively sponsors H-1B visas in FY 2025. In the most recent fiscal year (FY 2025), NGM BIOPHARMACEUTICALS filed 1 H-1B labor condition applications with 1 certified and 0 denied, at a median salary of $140,300. Across FY 2020–2025, they have filed 25 total H-1B applications with 23 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. NGM BIOPHARMACEUTICALS sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), NGM BIOPHARMACEUTICALS filed 1 H-1B applications, with 1 certified and 0 denied. Over 6 years of data, NGM BIOPHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

NGM BIOPHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 25 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating NGM BIOPHARMACEUTICALS as a potential H-1B sponsor.

This is an excellent approval rate, indicating NGM BIOPHARMACEUTICALS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

NGM BIOPHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 23 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles NGM BIOPHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at NGM BIOPHARMACEUTICALS:

The most frequently sponsored role is Senior Research Associate with 5 filings at a median salary of $101,816. This is followed by Associate Director, Clinical Operations (3 filings) and Research Scientist I.

NGM BIOPHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where NGM BIOPHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top NGM BIOPHARMACEUTICALS H-1B locations:

The largest H-1B hub for NGM BIOPHARMACEUTICALS is South San Francisco, CA with 22 filings at a median salary of $120,000. The highest-paying location is South San Francisco, CA at $120,000 median. Salaries range from $110,469 to $120,000 across office locations.

NGM BIOPHARMACEUTICALS's median H-1B salary has increased by +46% from FY 2020 ($96,000) to FY 2025 ($140,300). Tracking salary trends over time reveals how NGM BIOPHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at NGM BIOPHARMACEUTICALS.

Year-by-year breakdown:

• FY 2021: $120,000 (4 certified)
• FY 2022: $120,615 (5 certified)
• FY 2023: $111,072 (4 certified)
• FY 2024: $132,000 (2 certified)
• FY 2025: $140,300 (1 certified)

This 46% growth reflects strong compensation adjustments at NGM BIOPHARMACEUTICALS, keeping pace with market demands for H-1B talent.

NGM BIOPHARMACEUTICALS primarily files H-1B applications at Wage Level II, accounting for 79% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making NGM BIOPHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 93% of positions at Level II or higher, NGM BIOPHARMACEUTICALS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

NGM BIOPHARMACEUTICALS's median H-1B salary of $111,072 is 7% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating NGM BIOPHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare NGM BIOPHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.

NGM BIOPHARMACEUTICALS's H-1B salaries are competitive with industry averages. The 23 total filings indicate active H-1B sponsorship.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. NGM BIOPHARMACEUTICALS files 7% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 23 certified filings, NGM BIOPHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.